How can the UK government resolve criticisms that failing to set PFOA blood thresholds creates a liability shield for manufacturers?

The current absence of specific concentration limits for Perfluorooctanoic acid (PFOA) in human blood creates a legal vacuum. Without these benchmarks, proving direct causation in toxic tort litigation becomes nearly impossible for victims. Manufacturers often argue that if no legal limit exists, they haven't technically caused harm. This creates a functional shield against accountability.

To fix this, the government could shift toward a precautionary framework. Setting health-based guidance values (HBGVs) would provide a yardstick for both regulators and courts. Instead of waiting for absolute certainty of harm, which scientific consensus often struggles to provide in real-time, the UK could adopt a preventative stance. This would involve establishing clear, science-backed thresholds that trigger mandatory reporting and mitigation strategies.

Another path involves updating the